Home LiteratureArticle Details
PMID: 15758166 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Floden AM, Li S, Combs CK

Abstract

Although abundant reactive microglia are found associated with beta-amyloid (Abeta) plaques in Alzheimer's disease (AD) brains, their contribution to cell loss remains speculative. A variety of studies have documented the ability of Abeta fibrils to directly stimulate microglia in vitro to assume a neurotoxic phenotype characterized by secretion of a plethora of proinflammatory molecules. Collectively, these data suggest that activated microglia play a direct role in contributing to neuron death in AD rather than simply a role in clearance after plaque deposition. Although it is clear the Abeta-stimulated microglia acutely secrete toxic oxidizing species, the identity of longer-lived neurotoxic agents remains less defined. We used Abeta-stimulated conditioned media from primary mouse microglia to identify more stable neurotoxic secretions. The NMDA receptor antagonists memantine and 2-amino-5-phosphopetanoic acid as well as soluble tumor necrosis factor alpha (TNFalpha) receptor protect neurons from microglial-conditioned media-dependent death, implicating the excitatory neurotransmitter glutamate and the proinflammatory cytokine TNFalpha as effectors of microglial-stimulated death. Neuron death occurs in an oxidative damage-dependent manner, requiring activity of inducible nitric oxide synthase. Toxicity results from coincident stimulation of the TNFalpha and NMDA receptors, because stimulations of either alone are insufficient to initiate cell death. These findings suggest the hypothesis that AD brains provide the appropriate microglial-mediated inflammatory environment for TNFalpha and glutamate to synergistically stimulate toxic activation of their respective signaling pathways in neurons as a contributing mechanism of cell death.

MeSH Terms
Amyloid beta-Peptides/pharmacology Animals Cell Death/drug effects,physiology Cells, Cultured Cerebral Cortex/drug effects,metabolism Culture Media, Conditioned/pharmacology Dose-Response Relationship, Drug Drug Synergism Female Glutamic Acid/metabolism Humans Mice Mice, Inbred C57BL Microglia/drug effects,metabolism Neurons/drug effects,metabolism Pregnancy Receptors, N-Methyl-D-Aspartate/agonists,metabolism Tumor Necrosis Factor-alpha/agonists,metabolism
Chemicals
Amyloid beta-Peptides Culture Media, Conditioned Receptors, N-Methyl-D-Aspartate Tumor Necrosis Factor-alpha Glutamic Acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Floden Angela M
Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, North Dakota 58202, USA.
Li Shanshan
Combs Colin K
References (87)
87 references, click to expand
  1. Metalloporphyrins are potent inhibitors of lipid peroxidation.
    Free Radic Biol Med. 1999 Mar;26(5-6):730-6 PMID: 10218663
  2. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease.
    J Biol Chem. 1999 May 28;274(22):15493-9 PMID: 10336441
  3. Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD.
    J Neuroimmunol. 1999 Jan 1;93(1-2):53-71 PMID: 10378869
  4. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide.
    Neuroscience. 1999;92(4):1465-74 PMID: 10426500
  5. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9409-14 PMID: 10430956
  6. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide.
    Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9879-84 PMID: 10449788
  7. A high plasma concentration of TNF-alpha is associated with dementia in centenarians.
    J Gerontol A Biol Sci Med Sci. 1999 Jul;54(7):M357-64 PMID: 10462168
  8. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.
    J Clin Immunol. 1999 Jul;19(4):223-30 PMID: 10471976
  9. Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma.
    Biochem Biophys Res Commun. 1999 Sep 16;263(1):251-6 PMID: 10486285
  10. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
    J Immunol. 1999 Oct 1;163(7):3963-8 PMID: 10490998
  11. Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity.
    Exp Neurol. 2000 Feb;161(2):442-52 PMID: 10686066
  12. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia.
    J Neurochem. 2000 Mar;74(3):1017-25 PMID: 10693932
  13. Na+-dependent high-affinity glutamate transport in macrophages.
    J Immunol. 2000 May 15;164(10):5430-8 PMID: 10799909
  14. Inflammation and Alzheimer's disease.
    Neurobiol Aging. 2000 May-Jun;21(3):383-421 PMID: 10858586
  15. Alzheimer's congress. Drug shows promise for advanced disease.
    Science. 2000 Jul 21;289(5478):375-7 PMID: 10939942
  16. Cytokines in CNS disorders: neurotoxicity versus neuroprotection.
    J Neural Transm Suppl. 2000;59:81-9 PMID: 10961421
  17. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition.
    Exp Brain Res. 2000 Sep;134(1):58-65 PMID: 11026726
  18. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.
    J Neurosci. 2000 Oct 15;20(20):7587-94 PMID: 11027218
  19. Evaluation of memantine for neuroprotection in dementia.
    Expert Opin Investig Drugs. 2000 Jun;9(6):1397-406 PMID: 11060751
  20. NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.
    J Neurosci. 2000 Dec 1;20(23):8831-7 PMID: 11102491
  21. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function.
    J Neurochem. 2001 Feb;76(3):846-54 PMID: 11158256
  22. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.
    J Neurosci. 2001 Feb 15;21(4):1179-88 PMID: 11160388
  23. Microglial secreted cathepsin B induces neuronal apoptosis.
    J Neurochem. 2001 Mar;76(5):1475-84 PMID: 11238732
  24. Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo.
    J Neurosci. 2001 Mar 15;21(6):2058-66 PMID: 11245689
  25. Astrocytes regulate N-methyl-D-aspartate receptor subunit composition increasing neuronal sensitivity to excitotoxicity.
    J Biol Chem. 2001 Jun 22;276(25):22446-52 PMID: 11306581
  26. Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid.
    J Neurosci Res. 2001 Jun 1;64(5):454-65 PMID: 11391700
  27. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease.
    J Neuropathol Exp Neurol. 2001 Sep;60(9):906-16 PMID: 11556547
  28. Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways.
    J Neurosci. 2002 Apr 15;22(8):3025-32 PMID: 11943805
  29. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia.
    J Neurosci. 2002 May 1;22(9):3484-92 PMID: 11978825
  30. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease.
    Redox Rep. 2002;7(4):199-206 PMID: 12396664
  31. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
    Brain Res. 2002 Dec 20;958(1):210-21 PMID: 12468047
  32. Involvement of protein kinase C in glutamate release from cultured microglia.
    Brain Res. 2003 Feb 7;962(1-2):122-8 PMID: 12543462
  33. The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain.
    Neurochem Res. 2003 Feb;28(2):307-18 PMID: 12608703
  34. Memantine in moderate-to-severe Alzheimer's disease.
    N Engl J Med. 2003 Apr 3;348(14):1333-41 PMID: 12672860
  35. Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression.
    J Neurochem. 2003 Apr;85(2):387-98 PMID: 12675915
  36. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.
    J Neurochem. 2003 May;85(4):925-34 PMID: 12716424
  37. Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia.
    J Neurochem. 2003 Sep;86(5):1057-71 PMID: 12911614
  38. Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells.
    J Neurosci Res. 2003 Sep 15;73(6):811-7 PMID: 12949907
  39. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide.
    Biochem J. 1992 Jan 15;281 ( Pt 2):419-24 PMID: 1310595
  40. Peroxynitrite formation from macrophage-derived nitric oxide.
    Arch Biochem Biophys. 1992 Nov 1;298(2):446-51 PMID: 1329657
  41. Heteromeric NMDA receptors: molecular and functional distinction of subtypes.
    Science. 1992 May 22;256(5060):1217-21 PMID: 1350383
  42. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite.
    Arch Biochem Biophys. 1992 Nov 1;298(2):438-45 PMID: 1416975
  43. Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide.
    FASEB J. 2004 Jan;18(1):164-6 PMID: 14630699
  44. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.
    J Neurochem. 2004 Jan;88(2):494-501 PMID: 14690537
  45. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    JAMA. 2004 Jan 21;291(3):317-24 PMID: 14734594
  46. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway.
    J Biol Chem. 2004 Jul 30;279(31):32869-81 PMID: 15155767
  47. Memantine enhances autonomy in moderate to severe Alzheimer's disease.
    Int J Geriatr Psychiatry. 2004 May;19(5):458-64 PMID: 15156547
  48. Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide.
    J Neurosci. 2004 Jul 7;24(27):6049-56 PMID: 15240796
  49. Inducible form of nitric oxide synthase expression in rat cortical neuronal cells in vitro.
    Neurobiol Dis. 2004 Oct;17(1):70-6 PMID: 15350967
  50. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
    Neuroscience. 2004;128(1):73-89 PMID: 15450355
  51. Noradrenaline up-regulates the neuronal and the inducible nitric oxide synthase isoforms in magnocellular neurons of rat brain slices.
    J Neurosci Res. 2004 Dec 1;78(5):683-90 PMID: 15495217
  52. Role of inducible nitric oxide synthase in N-methyl-d-aspartic acid-induced strio-nigral degeneration.
    Brain Res. 2004 Dec 10;1029(1):103-13 PMID: 15533321
  53. Elevated circulating tumor necrosis factor levels in Alzheimer's disease.
    Neurosci Lett. 1991 Aug 19;129(2):318-20 PMID: 1745413
  54. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.
    J Biol Chem. 1991 Mar 5;266(7):4244-50 PMID: 1847917
  55. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
    Science. 1990 Feb 2;247(4942):571-4 PMID: 2154034
  56. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels.
    Eur J Pharmacol. 1989 Aug 3;166(3):591-2 PMID: 2553441
  57. Excitatory amino acids and Alzheimer's disease.
    Neurobiol Aging. 1989 Sep-Oct;10(5):593-602 PMID: 2554168
  58. 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation.
    Neurosci Lett. 1981 Jan 1;21(1):77-81 PMID: 6111052
  59. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9328-32 PMID: 7568127
  60. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain.
    Neurochem Int. 1995 Jul;27(1):119-37 PMID: 7655344
  61. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures.
    Dev Neurosci. 1994;16(3-4):172-9 PMID: 7705222
  62. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis.
    Dev Neurosci. 1993;15(6):417-22 PMID: 7835247
  63. Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10883-7 PMID: 7971977
  64. 'Footprinting' proteins on DNA with peroxonitrous acid.
    Nucleic Acids Res. 1993 May 25;21(10):2473-8 PMID: 8389444
  65. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.
    J Neurochem. 1993 May;60(5):1589-604 PMID: 8473885
  66. beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity.
    Brain Res. 1996 May 13;720(1-2):93-100 PMID: 8782901
  67. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.
    J Exp Med. 1996 Oct 1;184(4):1425-33 PMID: 8879214
  68. Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits.
    J Pharmacol Exp Ther. 1996 Nov;279(2):515-23 PMID: 8930153
  69. Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry.
    J Biol Chem. 1997 Feb 7;272(6):3465-70 PMID: 9013592
  70. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
    J Pharmacol Exp Ther. 1997 Feb;280(2):614-20 PMID: 9023271
  71. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo.
    J Biol Chem. 1997 Feb 21;272(8):4959-63 PMID: 9030556
  72. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia.
    J Neurosci. 1997 Apr 1;17(7):2284-94 PMID: 9065490
  73. Widespread peroxynitrite-mediated damage in Alzheimer's disease.
    J Neurosci. 1997 Apr 15;17(8):2653-7 PMID: 9092586
  74. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock.
    Br J Pharmacol. 1997 Jan;120(2):259-67 PMID: 9117118
  75. Diurnal variation of TNF alpha in the rat brain.
    Neuroreport. 1997 Mar 3;8(4):915-8 PMID: 9141064
  76. Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells.
    J Neuroimmunol. 1997 Sep;78(1-2):152-61 PMID: 9307240
  77. Frequency of stages of Alzheimer-related lesions in different age categories.
    Neurobiol Aging. 1997 Jul-Aug;18(4):351-7 PMID: 9330961
  78. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration.
    J Neurosci Res. 1997 Sep 15;49(6):681-97 PMID: 9335256
  79. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  80. Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons.
    J Neurosci Res. 1997 Dec 15;50(6):990-9 PMID: 9452013
  81. The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons.
    J Neurochem. 1998 May;70(5):1876-86 PMID: 9572271
  82. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1.
    J Neurophysiol. 1998 Jul;80(1):452-7 PMID: 9658063
  83. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.
    J Neurosci. 1998 Oct 15;18(20):8126-32 PMID: 9763459
  84. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling.
    Biochem Pharmacol. 1998 Oct 15;56(8):915-20 PMID: 9776301
  85. Potentiation of N-methyl-D-aspartate-mediated neurotoxicity by immunostimulated murine microglia.
    J Neurosci Res. 1998 Oct 1;54(1):17-26 PMID: 9778146
  86. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor.
    J Cereb Blood Flow Metab. 1998 Dec;18(12):1283-7 PMID: 9850139
  87. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.
    J Neurosci. 1999 Feb 1;19(3):928-39 PMID: 9920656
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2005-03-09
Pages
2566-75
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6725188
Subset
IM
Grants
NCRR NIH HHS · P20 RR017699 · United States
NCRR NIH HHS · 1 P20 RR17699-01 · United States
NIA NIH HHS · 1 R03 AG20294-01 · United States
NIA NIH HHS · 1 R15 AG16192-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com